LIVZON PHARMA(01513.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 576.91 million, YoY decrease of 9.39%

NewTimeSpace · 2026/04/24 09:58 · By Zeyu Wu

Tags：

LIVZON PHARMA 01513.HK financials

Related Topics

ETF
Harvest CSI Battery Thematic ETF(562880) Rises 0.96%, Sees Net Inflow of 67.0568 Million Yuan Over the Past 5 Trading Days
ETF
Fullgoal CSI Military Top ETF (512710) Falls 2.38%, Latest AUM Reaches 9.656 Billion Yuan
ETF
Harfor CSI Artificial Industry ETF(515980) Falls 3.06%, Latest AUM Reaches 8.299 Billion Yuan
ETF
Guotai CSI All Share Communication Equipment ETF (515880) Falls 3.30%, Sees Net Inflow of 3.267 Billion Yuan for Four Consecutive Days
ETF
ChinaAMC China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF(588170) Rises 0.56%, Sees AUM Growth of 83.7543 Million Yuan Over the Past Month
ETF
Ping An CSI Medicine and Medical Device Innovation ETF(516820) Rises 0.28%, Valuation Lower Than Over 96.09% of the Time in the Past Year
ETF
Penghua CSI Alcoholic Drink Index ETF(512690) Rises 0.61% Against the Trend, Sees Net Inflow of 199 Million Yuan Over the Past 5 Trading Days
ETF
Guotai SSE State Owned Enterprise Dividends ETF(510720) Rises 0.20%, Sees Net Inflow of 142 Million Yuan Over the Past 16 Trading Days
ETF
Guotai CSI Coal ETF(515220) Rises 0.88%, Aiming for Fourth Consecutive Gain
ETF
Hwabao WP CSI Subdivision Chemical Industry Theme ETF(516020) Rises 1.05%, Sees AUM Growth of 2.721 Billion Yuan Over the Past Six Months

Scan QR Code

Download App